Immunogenicity of anti-Haemophilus influenzae type b CRM 197 conjugate following mucosal vaccination with oligodeoxynucleotide containing immunostimulatory sequences as adjuvant

By Mariotti S.   Teloni R.   von Hunolstein C.   Romagnoli G.   Orefici G.   Nisini R.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2229-2239

Elsevier

Access to resources Recommend Favorite

Association of placental transfer of anti-Haemophilus influenzae type b polysaccharide antibodies with their V regions

By Park M.K.   Englund J.A.   Glezen W.P.   Siber G.R.   Nahm M.H.  

Vaccine, Vol. 14, Iss. 13, 1996-09 ,pp. : 1219-1222

Elsevier

Access to resources Recommend Favorite

Molecular size characterization of Haemophilus influenzae type b polysaccharide-protein conjugate vaccines

By Plumb J.E.   Yost S.E.  

Vaccine, Vol. 14, Iss. 5, 1996-04 ,pp. : 399-404

Elsevier

Access to resources Recommend Favorite

Development of a guinea pig model to assess immunogenicity of Haemophilus influenzae type b capsular polysaccharide conjugate vaccines

By Siber G.R.   Anderson R.   Habafy M.   Gupta R.K.  

Vaccine, Vol. 13, Iss. 6, 1995-04 ,pp. : 525-531

Elsevier

Access to resources Recommend Favorite

Effect of physico-chemical modification on the immunogenicity of Haemophilus influenzae type b oligosaccharide-CRM 197 conjugate vaccines

By Bolgiano B.   Mawas F.   Yost S.E.   Crane D.T.   Lemercinier X.   Corbel M.J.  

Vaccine, Vol. 19, Iss. 23, 2001-04 ,pp. : 3189-3200

Elsevier

Access to resources Recommend Favorite